Nimodipine Overview Categories 12 Cardiovascular drugs12.3 Anti-hypertensives12.3.2 Calcium antagonists 24 Psychotherapeutic drugs24.6 Cerebrovascular drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Nimodipine Manufacturers of Nimodipine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Nimodipine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 0.5 to 1 mg/hr0.75 (0.75)As recommended.IV InfFor first 2 hrs. then 2mg/hr 5-14 days60 mg60 (60)4 hourlyPOStart within 4 days of subarachnoid hemorrhage and continued for 21 days Paedriatic Dosage (20kg) Not recommended for this age group Neonatal Dosage (3kg) Not recommended in this age group High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Nimodipine Back to top Manufacturers of Nimodipine in Pakistan A.J Bayer Global High-Q Mass Mediate Medisure Pearl Pulse Spencer Back to top Previous Drug Generic - Next Drug Generic
Nimodipine Overview Categories 12 Cardiovascular drugs12.3 Anti-hypertensives12.3.2 Calcium antagonists 24 Psychotherapeutic drugs24.6 Cerebrovascular drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Nimodipine Manufacturers of Nimodipine Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Nimodipine's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 0.5 to 1 mg/hr0.75 (0.75)As recommended.IV InfFor first 2 hrs. then 2mg/hr 5-14 days60 mg60 (60)4 hourlyPOStart within 4 days of subarachnoid hemorrhage and continued for 21 days Paedriatic Dosage (20kg) Not recommended for this age group Neonatal Dosage (3kg) Not recommended in this age group High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Nimodipine Back to top Manufacturers of Nimodipine in Pakistan A.J Bayer Global High-Q Mass Mediate Medisure Pearl Pulse Spencer Back to top Previous Drug Generic - Next Drug Generic